tsukiko.kurokawa@metagentx.com (Yamagata, Japan, June 6, 2024) Metagen Therapeutics, Inc. (Headquarters: Tsuruoka City, Yamagata Prefecture; President & CEO: Taku Nakahara), a company focusing on drug discovery and development of intestinal microbiome-based therapeutics for various diseases, will have its Chief Scientific Officer Jun Terauchi as a special speaker at The 28th Annual Meeting of Intestinal Microbiology, to be held on June 25 and 26, 2024.
The theme of the 28th Annual Meeting of Intestinal Microbiology is
“Gut Microbiota Research Opens the Door to a Healthy Society – Latest Research Trends and Efforts Toward Social Implementation”.
■Schedule
DAY1 Tuesday, 25th, June
13:40-14:30 Special Lecture「Microbiome research for drug discovery and social implementation ~Precompetitive initiatives through industry-academia-government collaboration~」
Jun Terauchi, Japan Microbiome Consortium／Metagen Therapeutics, Inc.
For more information, please visit the following website: